1. Home
  2. BWLP vs LMAT Comparison

BWLP vs LMAT Comparison

Compare BWLP & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BW LPG Limited

BWLP

BW LPG Limited

HOLD

Current Price

$21.44

Market Cap

3.1B

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$91.74

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWLP
LMAT
Founded
1935
1983
Country
Singapore
United States
Employees
1444
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.2B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BWLP
LMAT
Price
$21.44
$91.74
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$105.80
AVG Volume (30 Days)
533.4K
246.0K
Earning Date
05-19-2026
05-05-2026
Dividend Yield
7.51%
0.93%
EPS Growth
N/A
30.57
EPS
N/A
0.68
Revenue
N/A
$249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
N/A
$8.88
P/E Ratio
$15.61
$135.79
Revenue Growth
N/A
13.53
52 Week Low
$11.59
$79.01
52 Week High
$22.92
$118.01

Technical Indicators

Market Signals
Indicator
BWLP
LMAT
Relative Strength Index (RSI) 59.71 35.10
Support Level $19.33 $89.81
Resistance Level $22.92 $92.25
Average True Range (ATR) 0.61 2.86
MACD 0.01 0.21
Stochastic Oscillator 73.20 16.39

Price Performance

Historical Comparison
BWLP
LMAT

About BWLP BW LPG Limited

BW LPG Ltd is an owner and operator of very large gas carriers. It operates in two segments: the Shipping segment, which includes LPG shipping and the Product Services segment, which includes the core shipping business. The Product Services segment derives the majority of the revenue.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: